Cargando…
Multidimensional Biomechanics-Based Score to Assess Disease Progression in Duchenne Muscular Dystrophy
(1) Background: Duchenne (DMD) is a rare neuromuscular disease that progressively weakens muscles, which severely impairs gait capacity. The Six Minute-Walk Test (6MWT), which is commonly used to evaluate and monitor the disease’s evolution, presents significant variability due to extrinsic factors...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861677/ https://www.ncbi.nlm.nih.gov/pubmed/36679627 http://dx.doi.org/10.3390/s23020831 |
_version_ | 1784874901515010048 |
---|---|
author | Migliorelli, Carolina Gómez-Martinez, Meritxell Subías-Beltrán, Paula Claramunt-Molet, Mireia Idelsohn-Zielonka, Sebastian Mas-Hurtado, Eudald Miralles, Felip Montolio, Marisol Roselló-Ruano, Marina Medina-Cantillo, Julita |
author_facet | Migliorelli, Carolina Gómez-Martinez, Meritxell Subías-Beltrán, Paula Claramunt-Molet, Mireia Idelsohn-Zielonka, Sebastian Mas-Hurtado, Eudald Miralles, Felip Montolio, Marisol Roselló-Ruano, Marina Medina-Cantillo, Julita |
author_sort | Migliorelli, Carolina |
collection | PubMed |
description | (1) Background: Duchenne (DMD) is a rare neuromuscular disease that progressively weakens muscles, which severely impairs gait capacity. The Six Minute-Walk Test (6MWT), which is commonly used to evaluate and monitor the disease’s evolution, presents significant variability due to extrinsic factors such as patient motivation, fatigue, and learning effects. Therefore, there is a clear need for the establishment of precise clinical endpoints to measure patient mobility. (2) Methods: A novel score (6M+ and 2M+) is proposed, which is derived from the use of a new portable monitoring system capable of carrying out a complete gait analysis. The system includes several biomechanical sensors: a heart rate band, inertial measurement units, electromyography shorts, and plantar pressure insoles. The scores were obtained by processing the sensor signals and via gaussian-mixture clustering. (3) Results: The 6M+ and 2M+ scores were evaluated against the North Star Ambulatory Assessment (NSAA), the gold-standard for measuring DMD, and six- and two-minute distances. The 6M+ and 2M+ tests led to superior distances when tested against the NSAA. The 6M+ test and the 2M+ test in particular were the most correlated with age, suggesting that these scores better characterize the gait regressions in DMD. Additionally, the 2M+ test demonstrated an accuracy and stability similar to the 6M+ test. (4) Conclusions: The novel monitoring system described herein exhibited good usability with respect to functional testing in a clinical environment and demonstrated an improvement in the objectivity and reliability of monitoring the evolution of neuromuscular diseases. |
format | Online Article Text |
id | pubmed-9861677 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98616772023-01-22 Multidimensional Biomechanics-Based Score to Assess Disease Progression in Duchenne Muscular Dystrophy Migliorelli, Carolina Gómez-Martinez, Meritxell Subías-Beltrán, Paula Claramunt-Molet, Mireia Idelsohn-Zielonka, Sebastian Mas-Hurtado, Eudald Miralles, Felip Montolio, Marisol Roselló-Ruano, Marina Medina-Cantillo, Julita Sensors (Basel) Article (1) Background: Duchenne (DMD) is a rare neuromuscular disease that progressively weakens muscles, which severely impairs gait capacity. The Six Minute-Walk Test (6MWT), which is commonly used to evaluate and monitor the disease’s evolution, presents significant variability due to extrinsic factors such as patient motivation, fatigue, and learning effects. Therefore, there is a clear need for the establishment of precise clinical endpoints to measure patient mobility. (2) Methods: A novel score (6M+ and 2M+) is proposed, which is derived from the use of a new portable monitoring system capable of carrying out a complete gait analysis. The system includes several biomechanical sensors: a heart rate band, inertial measurement units, electromyography shorts, and plantar pressure insoles. The scores were obtained by processing the sensor signals and via gaussian-mixture clustering. (3) Results: The 6M+ and 2M+ scores were evaluated against the North Star Ambulatory Assessment (NSAA), the gold-standard for measuring DMD, and six- and two-minute distances. The 6M+ and 2M+ tests led to superior distances when tested against the NSAA. The 6M+ test and the 2M+ test in particular were the most correlated with age, suggesting that these scores better characterize the gait regressions in DMD. Additionally, the 2M+ test demonstrated an accuracy and stability similar to the 6M+ test. (4) Conclusions: The novel monitoring system described herein exhibited good usability with respect to functional testing in a clinical environment and demonstrated an improvement in the objectivity and reliability of monitoring the evolution of neuromuscular diseases. MDPI 2023-01-11 /pmc/articles/PMC9861677/ /pubmed/36679627 http://dx.doi.org/10.3390/s23020831 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Migliorelli, Carolina Gómez-Martinez, Meritxell Subías-Beltrán, Paula Claramunt-Molet, Mireia Idelsohn-Zielonka, Sebastian Mas-Hurtado, Eudald Miralles, Felip Montolio, Marisol Roselló-Ruano, Marina Medina-Cantillo, Julita Multidimensional Biomechanics-Based Score to Assess Disease Progression in Duchenne Muscular Dystrophy |
title | Multidimensional Biomechanics-Based Score to Assess Disease Progression in Duchenne Muscular Dystrophy |
title_full | Multidimensional Biomechanics-Based Score to Assess Disease Progression in Duchenne Muscular Dystrophy |
title_fullStr | Multidimensional Biomechanics-Based Score to Assess Disease Progression in Duchenne Muscular Dystrophy |
title_full_unstemmed | Multidimensional Biomechanics-Based Score to Assess Disease Progression in Duchenne Muscular Dystrophy |
title_short | Multidimensional Biomechanics-Based Score to Assess Disease Progression in Duchenne Muscular Dystrophy |
title_sort | multidimensional biomechanics-based score to assess disease progression in duchenne muscular dystrophy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861677/ https://www.ncbi.nlm.nih.gov/pubmed/36679627 http://dx.doi.org/10.3390/s23020831 |
work_keys_str_mv | AT migliorellicarolina multidimensionalbiomechanicsbasedscoretoassessdiseaseprogressioninduchennemusculardystrophy AT gomezmartinezmeritxell multidimensionalbiomechanicsbasedscoretoassessdiseaseprogressioninduchennemusculardystrophy AT subiasbeltranpaula multidimensionalbiomechanicsbasedscoretoassessdiseaseprogressioninduchennemusculardystrophy AT claramuntmoletmireia multidimensionalbiomechanicsbasedscoretoassessdiseaseprogressioninduchennemusculardystrophy AT idelsohnzielonkasebastian multidimensionalbiomechanicsbasedscoretoassessdiseaseprogressioninduchennemusculardystrophy AT mashurtadoeudald multidimensionalbiomechanicsbasedscoretoassessdiseaseprogressioninduchennemusculardystrophy AT mirallesfelip multidimensionalbiomechanicsbasedscoretoassessdiseaseprogressioninduchennemusculardystrophy AT montoliomarisol multidimensionalbiomechanicsbasedscoretoassessdiseaseprogressioninduchennemusculardystrophy AT roselloruanomarina multidimensionalbiomechanicsbasedscoretoassessdiseaseprogressioninduchennemusculardystrophy AT medinacantillojulita multidimensionalbiomechanicsbasedscoretoassessdiseaseprogressioninduchennemusculardystrophy |